3D-Cardiac Tissue Engineering For the Cell Therapy of Heart Failure

3D-Cardiac Tissue Engineering For the Cell Therapy of Heart Failure

Abstract

A pharmaceutical composition comprising biodegradable gel-based matrix, at least one active agent and stem cells able to differentiate into cardiac tissue under the form of a patch, for the treatment of heart failure due to myocardial infarction is disclosed.

Year:  2008

Country:  US

Doc No:  2008226726

 

For more information visit espacenet.com

Read more